For the first time, scientists from Jena succeeded to cultivate and functionally characterize a total of 79 bacteria strains, which had previously received little…
A new EU report sees only slow progress in the fight against AMR. The BEAM Alliance urges for more support for SMEs. Although some…
A drug combo breaking antibiotic resistance of Gram-negative priority pathogens has been selected under the ENABLE programme of the Innovative Medicines Initiative (IMI). Efficacy…
Despite challenging markets new players are entering the field to advance drug development in the fight against antimicrobial resistance. It is already a widely…
Antibiotic developers struggle with uncertain market conditions, weak reimbursement schemes and low turnover once a drug is approved. Experts are trying to figure out…